The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
Don't forget to register and join us Saturday, November 16, 2019 at 8:30 AM OncTalk 2019 - Controversies in Managing NSCLC - Connecting Patients to...
With the plethora of Medicare options available, here is an overview of Medicare terms and options along with things to consider when choosing a...
What are Patient Reported Outcomes and why are they important to patients? Patient reported outcomes (PROs) can be thought of as any report or...
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered this past year (virtually) to review information presented at ASCO and ESMO 2021, regarding patients dealing with a Lung Cancer diagnosis.
For this series, the doctors discuss new trials for patients with NSCLC and SCLC. The video discussions cover the following topics:
Hi! I recently had an xray for pain to my R rib (after helping someone move). Came back contusion but found a 1cm nodular density projecting over the L lower lung fields. CT of chest in 2011 detected nothing on L but 6mm on R. Lung screening 2014 detected 4 to 5 mm on R and a new 3 to 4 mm on lower L. So if it is the same nodule lower L grew from 3 to 4 mm to 1 cm over 7 years. I am scheduled for follow up CT in 9 days. My dilemma is #1 that I am worried about this growth and #2 that I am scheduled to leave for Puerto Vallarta for 2.5 weeks.
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021.
For this series, the doctors discuss new trials for patients with NSCLC. In this video, the doctors discuss IMpower010, and Adjuvant Atezolizumab After Chemotherapy in Resected Stage I-IIIA NSCLC.
AfterCT, tissue biopsy and pet scan, I was diagnosed as stage 1 b lung non small adenocacinoma, exon19 deletion EGFR mutation and TP53 mutation. When the surgeon opened up, she found a few drops on my same side lung plural, so she closed up and did not perused the surgery we planned and told me it is stage 4 and I can not have surgery any more. I was really disappointed! but my most recent blood liquid biopsy shows that There is no detected blood cancer cell or any mutations in my blood.
I need information on adrenal metastasis from multifocal nsclc. Initial dx march 2019 surgical lobectomy complications eventually had to undergo pleurodesis 2019. Lungs stable. Now 3+cm adrenal tumor, new since June scan. Need help: radiation best or surgery? Complications? I live in Seattle
Thanks Carole
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.